Literature DB >> 20179980

A case of dermatomyositis with "liver disease associated with rheumatoid diseases" positive for anti-liver-kidney microsome-1 antibody.

Shinji Noda1, Yoshihide Asano, Zenshiro Tamaki, Tomonori Takekoshi, Makoto Sugaya, Shinichi Sato.   

Abstract

We reported a case of dermatomyositis (DM) with liver disturbance in a 50-year-old Japanese female. She presented with fever, muscle weakness, and typical DM rashes. On clinical and serological examinations, the liver impairment was initially diagnosed as probable autoimmune hepatitis, which was denied by a histological study despite positive anti-liver-kidney microsome-1 antibody. Finally, she was diagnosed as having DM with "liver disease associated with rheumatoid diseases", and treatment with oral prednisone (40 mg/day) achieved normalization of liver and muscle enzyme levels as well as improvement of symptoms associated with DM. Liver involvement in patients with polymyositis (PM)/DM has not been well described and is considered to be uncommon. Full clarification of the etiology of liver impairment with a histological examination in collagen diseases including PM/DM is useful to determine the proper dose of corticosteroids for the treatment of collagen diseases and their liver complications.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20179980     DOI: 10.1007/s10067-010-1397-3

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  6 in total

1.  Polymyositis, cranial neuropathy, autoimmune hepatitis, and hepatitis C.

Authors:  I Marie; H Levesque; H Courtois; A François; G Riachi
Journal:  Ann Rheum Dis       Date:  2000-10       Impact factor: 19.103

2.  The liver in collagen diseases: pathologic study of 160 cases with particular reference to hepatic arteritis, primary biliary cirrhosis, autoimmune hepatitis and nodular regenerative hyperplasia of the liver.

Authors:  T Matsumoto; S Kobayashi; H Shimizu; M Nakajima; S Watanabe; N Kitami; N Sato; H Abe; Y Aoki; T Hoshi; H Hashimoto
Journal:  Liver       Date:  2000-10

Review 3.  Hepatic manifestations of autoimmune rheumatic diseases.

Authors:  S Abraham; S Begum; D Isenberg
Journal:  Ann Rheum Dis       Date:  2004-02       Impact factor: 19.103

4.  International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis.

Authors:  F Alvarez; P A Berg; F B Bianchi; L Bianchi; A K Burroughs; E L Cancado; R W Chapman; W G Cooksley; A J Czaja; V J Desmet; P T Donaldson; A L Eddleston; L Fainboim; J Heathcote; J C Homberg; J H Hoofnagle; S Kakumu; E L Krawitt; I R Mackay; R N MacSween; W C Maddrey; M P Manns; I G McFarlane; K H Meyer zum Büschenfelde; M Zeniya
Journal:  J Hepatol       Date:  1999-11       Impact factor: 25.083

5.  Clinical features of liver disturbance in rheumatoid diseases: clinicopathological study with special reference to the cause of liver disturbance.

Authors:  Hideyuki Kojima; Masahito Uemura; Shinya Sakurai; Tatsuichi Ann; Yoshinobu Ishii; Hiroo Imazu; Masahide Yoshikawa; Kunio Ichijima; Hiroshi Fukui
Journal:  J Gastroenterol       Date:  2002       Impact factor: 7.527

6.  Simplified criteria for the diagnosis of autoimmune hepatitis.

Authors:  Elke M Hennes; Mikio Zeniya; Albert J Czaja; Albert Parés; George N Dalekos; Edward L Krawitt; Paulo L Bittencourt; Gilda Porta; Kirsten M Boberg; Harald Hofer; Francesco B Bianchi; Minoru Shibata; Christoph Schramm; Barbara Eisenmann de Torres; Peter R Galle; Ian McFarlane; Hans-Peter Dienes; Ansgar W Lohse
Journal:  Hepatology       Date:  2008-07       Impact factor: 17.425

  6 in total
  1 in total

1.  Liver dysfunction in anti-melanoma differentiation-associated gene 5 antibody-positive patients with dermatomyositis.

Authors:  Takao Nagashima; Yasuyuki Kamata; Masahiro Iwamoto; Hitoaki Okazaki; Noriyoshi Fukushima; Seiji Minota
Journal:  Rheumatol Int       Date:  2019-02-21       Impact factor: 2.631

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.